α1-adrenoceptor subtypes and α1- adrenoceptor antagonists

Yakugaku Zasshi

Volumn 126, Issue SPEC. ISS., 2006, Pages 187-198

  Muramatsu, Ikunobu ^a   Suzuki, Fumiko ^a   Tanaka, Takashi ^a   Yamamoto, Hatsumi ^a   Morishima, Shigeru ^a  

^a University of Fukui   (Japan)

Author keywords

1 adrenoceptor (subtype); 1 adrenoceptor antagonist; Blood vessel; Lower urinary tract; Tolerance

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; NAFTOPIDIL; NORADRENALIN; PRAZOSIN; SILODOSIN; TAMSULOSIN; TERAZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NAPHTHALENE DERIVATIVE; PIPERAZINE DERIVATIVE; SULFONAMIDE;

AMINO ACID SEQUENCE; COMPUTER MODEL; DRUG EFFECT; HUMAN; MESENTERIC ARTERY; NONHUMAN; PHENOTYPE; PROSTATE; PROSTATE HYPERTROPHY; RAT STRAIN; REVIEW; URINARY TRACT OBSTRUCTION; ANIMAL; CHEMISTRY; CLASSIFICATION; DRUG ANTAGONISM; DRUG DESIGN; DRUG TOLERANCE; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; URETHRA OBSTRUCTION;

ADRENERGIC ALPHA-ANTAGONISTS; AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; DRUG DESIGN; DRUG TOLERANCE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NAPHTHALENES; PIPERAZINES; PROSTATIC HYPERPLASIA; RECEPTORS, ADRENERGIC, ALPHA-1; SULFONAMIDES; URETHRAL OBSTRUCTION;

EID: 33644997492     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.187     Document Type: Review

References (39)

1. Smiley R., Kwatra M., Schwinn D., J. Cardiothorac. Vasc. Anesth., 12, 80-95 (1998).
2. Michelotti G. A., Price D. T., Schwinn D. A., Pharmacol. Ther., 88, 281-309 (2000).
3. Graham R. M., Perez D. M., Hwa J., Piascik M. T., Circ. Res., 78, 737-749 (1996).
4. Chapple C. R., Eur. Urol., 29, 129-144 (1996).
5. Cooper K. L., McKiernan J. M., Kaplan S. A., Drugs, 57, 9-17 (1999).
6. Hieble J. P., Bylund D. B., Clarke D. E., Eikenberg D. C., Langer S. Z., Lefkowitz R. J., Minneman K. P., Ruffolo Jr. R. R., Pharmacol. Rev., 47, 267-270 (1995).
7. Murata S., Taniguchi T., Muramatsu I., Br. J. Pharmacol., 127, 19-26 (1999).
8. Piao H., Taniguchi T., Nakamura S., Zhu J., Suzuki F., Mikami D., Muramatsu I., Eur. J. Pharmacol., 396, 9-17 (2000).
9. Muramatsu I., Murata S., Isaka M., Piao H. L., Zhu J., Suzuki F., Miyamoto S., Oshita M., Watanabe Y., Life Sci., 62, 1461-1465 (1998).
10. Murata S., Taniguchi T., Takahashi M., Okada K., Akiyama K., Muramatsu I., J. Urol., 164, 578-583 (2000).
11. Muramatsu I., Oshita M., Ohmura T., Kigoshi S., Akino H., Gobara M., Okada K., Br. J. Urol., 74, 572-575 (1994).
12. Ishiguro M., Futabayashi Y., Ohnuki T., Ahmed M., Muramatsu I., Nagatomo T., Life Sci., 71, 2531-2541 (2002).
13. Suzuki F., Taniguchi T., Takauji R., Murata S., Muramatsu I., Br. J. Pharmacol., 129, 1569-1576 (2000).
14. Stanasila L., Peres J. B., Vogel H., Cotecchia S., J. Biol. Chem., 278, 40239-40251 (2003).
15. Pupo A. S., Uberti M. A., Minneman K. P., Eur. J. Pharmacol., 462, 1-8 (2003).
16. Garcia-Sainz J. A., Villalobos-Molina R., Eur. J. Pharmacol., 500, 113-120 (2004).
17. Hawrylyshyn K. A., Michelotti G. A., Coge F., Guenin S.-P., Schwinn D. A., Trends Pharmacol. Sci., 25, 449-455 (2004).
18. Milligan G., Pediani J., Fidock M., Lopez-Gimenez J. F., Biochem. Soc. Trans., 32, 847-850 (2004).
19. Israilova M., Tanaka T., Suzuki F., Morishima S., Muramatsu I., J. Pharmacol. Exp. Ther., 309, 259-266 (2004).
20. Lefkowitz R. J., Cotecchia S., Samama P., Costa T., Trends Pharmacol. Sci., 14, 303-307 (1993).
21. Milligan G., Bomd R. A., Trends Pharmacol. Sci., 18, 468-474 (1997).
22. Zhu J., Taniguchi T., Takauji R., Suzuki F., Tanaka T., Muramatsu I., Br. J. Pharmacol., 131, 546-552 (2000).
23. Price D., Lefkowitz D., Caron M., Schwinn D., Berkowitz D., Mol. Pharmacol., 45, 171-175 (1994).
24. Borst S. E., Oliver R. J., Scarpace P. J., J. Gerontol., 49, B18-B21 (1994).
25. Brodde O. E., Michel M. C., Pharmacol. Rev., 51, 651-690 (1999).
26. Terzic A., Puceat M., Vassort G., Vogel S. M., Pharmacol. Rev., 45, 147-175 (1993).
27. Rudner X. L., Berkowitz D. E., Booth J. V., Funk B. L., Cozart K. L., D'Amico E. B., El-Moalem H., Page S. O., Richardson C. D., Winters B., Marucci L., Schwinn D. A., Circulation, 100, 2336-2343 (1999).
28. Price D., Schwinn D., Lomasney J., Allen L., Caron M., Lefkowitz R., J. Urol., 150, 546-551 (1993).
29. Muramatsu I., Ohmura T., Kigoshi S., Hashimoto S., Oshita M., Br. J. Pharmacol., 99, 197-201 (1990).
30. Muramatsu I., Ohmura T., Hashimoto S., Oshita M., Pharmacol. Commun., 6, 23-28 (1995).
31. Muramatsu I., Tanaka T., Suzuki F., Zhang L., Hiraizumi-Hiraoka Y., Anisuzzaman A. S. M., Yamamoto H., Horinouchi T., Morishima S., J. Pharmacol. Sci., 98, 331-339 (2005).
32. Hiraizumu-Hiraoka Y., Tanaka T., Yamamoto H., Suzuki F., Muramatsu I., J. Pharmacol. Exp. Ther., 310, 995-1002 (2004).
33. Bristow M. R., J. Am. Coll. Cardiol., 22, 61A-71A (1993).
34. Julius S., Am. Heart J., 122, 886-891 (1991).
35. Kawabe K., Ueno A., Takimoto Y., Aso Y., Kato H., J. Urol., 144, 908-912 (1990).
36. Chappl C. R., Wyndaele J. I., Nordling J., Boeminghaus F., Ypma AFGVM., Abrams P., Eur. Urol., 29, 155-167 (1996).
37. Vincent J., Dachman W., Blaschke T. F., Hoffman B. B., J. Clin. Invest., 90, 1763-1768 (1992).
38. Ruzicka M., Leenen F. H., Can. J. Cardiol., 18, 1317-1327 (2002).
39. Zhang L., Taniguchi T., Tanaka T., Shinozuka K., Kunitomo M., Nishiyama M., Kamata K., Muramatsu I., Br. J. Pharmacol., 135, 1757-1764 (2002).